These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7698046)

  • 1. Promotion and acceleration of diabetic ulcer healing by arginine-glycine-aspartic acid (RGD) peptide matrix. RGD Study Group.
    Steed DL; Ricotta JJ; Prendergast JJ; Kaplan RJ; Webster MW; McGill JB; Schwartz SL
    Diabetes Care; 1995 Jan; 18(1):39-46. PubMed ID: 7698046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated healing of chronic sickle-cell leg ulcers treated with RGD peptide matrix. RGD Study Group.
    Wethers DL; Ramirez GM; Koshy M; Steinberg MH; Phillips G; Siegel RS; Eckman JR; Prchal JT
    Blood; 1994 Sep; 84(6):1775-9. PubMed ID: 8080985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study.
    Richard JL; Parer-Richard C; Daures JP; Clouet S; Vannereau D; Bringer J; Rodier M; Jacob C; Comte-Bardonnet M
    Diabetes Care; 1995 Jan; 18(1):64-9. PubMed ID: 7698050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers.
    Hanft JR; Pollak RA; Barbul A; van Gils C; Kwon PS; Gray SM; Lynch CJ; Semba CP; Breen TJ
    J Wound Care; 2008 Jan; 17(1):30-2, 34-7. PubMed ID: 18210954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: A phase III multicenter, double-blind, randomized, placebo-controlled trial.
    Park KH; Han SH; Hong JP; Han SK; Lee DH; Kim BS; Ahn JH; Lee JW
    Diabetes Res Clin Pract; 2018 Aug; 142():335-344. PubMed ID: 29902542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study.
    Kalani M; Apelqvist J; Blombäck M; Brismar K; Eliasson B; Eriksson JW; Fagrell B; Hamsten A; Torffvit O; Jörneskog G
    Diabetes Care; 2003 Sep; 26(9):2575-80. PubMed ID: 12941721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical application of the bee hive protectant propolis is well tolerated and improves human diabetic foot ulcer healing in a prospective feasibility study.
    Henshaw FR; Bolton T; Nube V; Hood A; Veldhoen D; Pfrunder L; McKew GL; Macleod C; McLennan SV; Twigg SM
    J Diabetes Complications; 2014; 28(6):850-7. PubMed ID: 25239451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated healing and reduced need for grafting in pediatric patients with burns treated with arginine-glycine-aspartic acid peptide matrix. RGD Study Group.
    Hansbrough JF; Herndon DN; Heimbach DM; Solem LD; Gamelli RL; Tompkins RG
    J Burn Care Rehabil; 1995; 16(4):377-87. PubMed ID: 8582916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study.
    Wieman TJ; Smiell JM; Su Y
    Diabetes Care; 1998 May; 21(5):822-7. PubMed ID: 9589248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin peptide Chrysalin stimulates healing of diabetic foot ulcers in a placebo-controlled phase I/II study.
    Fife C; Mader JT; Stone J; Brill L; Satterfield K; Norfleet A; Zwernemann A; Ryaby JT; Carney DH
    Wound Repair Regen; 2007; 15(1):23-34. PubMed ID: 17244316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of the combination of isosorbide dinitrate spray and chitosan gel for the treatment of diabetic foot ulcers: A double-blind, randomized, clinical trial.
    Totsuka Sutto SE; Rodríguez Roldan YI; Cardona Muñoz EG; Garcia Cobian TA; Pascoe Gonzalez S; Martínez Rizo A; Mendez Del Villar M; García Benavides L
    Diab Vasc Dis Res; 2018 Jul; 15(4):348-351. PubMed ID: 29682995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic ulcers.
    Niezgoda JA; Van Gils CC; Frykberg RG; Hodde JP
    Adv Skin Wound Care; 2005 Jun; 18(5 Pt 1):258-66. PubMed ID: 15942317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NorLeu3-A(1-7) stimulation of diabetic foot ulcer healing: results of a randomized, parallel-group, double-blind, placebo-controlled phase 2 clinical trial.
    Balingit PP; Armstrong DG; Reyzelman AM; Bolton L; Verco SJ; Rodgers KE; Nigh KA; diZerega GS
    Wound Repair Regen; 2012; 20(4):482-90. PubMed ID: 22672145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical platelet-derived growth factor vs placebo therapy of diabetic foot ulcers offloaded with windowed casts: a randomized, controlled trial.
    Ma C; Hernandez MA; Kirkpatrick VE; Liang LJ; Nouvong AL; Gordon II
    Wounds; 2015 Apr; 27(4):83-91. PubMed ID: 25855851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of PDRN, an adenosine receptor A2A agonist, on the healing of chronic diabetic foot ulcers: results of a clinical trial.
    Squadrito F; Bitto A; Altavilla D; Arcoraci V; De Caridi G; De Feo ME; Corrao S; Pallio G; Sterrantino C; Minutoli L; Saitta A; Vaccaro M; Cucinotta D
    J Clin Endocrinol Metab; 2014 May; 99(5):E746-53. PubMed ID: 24483158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of short-contact topical tretinoin therapy for foot ulcers in patients with diabetes.
    Tom WL; Peng DH; Allaei A; Hsu D; Hata TR
    Arch Dermatol; 2005 Nov; 141(11):1373-7. PubMed ID: 16301384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human epidermal growth factor enhances healing of diabetic foot ulcers.
    Tsang MW; Wong WK; Hung CS; Lai KM; Tang W; Cheung EY; Kam G; Leung L; Chan CW; Chu CM; Lam EK
    Diabetes Care; 2003 Jun; 26(6):1856-61. PubMed ID: 12766123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Multinational, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy of Cyclical Topical Wound Oxygen (TWO2) Therapy in the Treatment of Chronic Diabetic Foot Ulcers: The TWO2 Study.
    Frykberg RG; Franks PJ; Edmonds M; Brantley JN; Téot L; Wild T; Garoufalis MG; Lee AM; Thompson JA; Reach G; Dove CR; Lachgar K; Grotemeyer D; Renton SC;
    Diabetes Care; 2020 Mar; 43(3):616-624. PubMed ID: 31619393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of topical phenytoin on healing in diabetic foot ulcers: a randomized controlled trial.
    Shaw J; Hughes CM; Lagan KM; Stevenson MR; Irwin CR; Bell PM
    Diabet Med; 2011 Oct; 28(10):1154-7. PubMed ID: 21480976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of intralesional recombinant human epidermal growth factor in diabetic foot ulcers in Mexican patients: a randomized double-blinded controlled trial.
    Gomez-Villa R; Aguilar-Rebolledo F; Lozano-Platonoff A; Teran-Soto JM; Fabian-Victoriano MR; Kresch-Tronik NS; Garrido-Espíndola X; Garcia-Solis A; Bondani-Guasti A; Bierzwinsky-Sneider G; Contreras-Ruiz J
    Wound Repair Regen; 2014; 22(4):497-503. PubMed ID: 25041620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.